Athira Pharma
ATHA
ATHA
89 hedge funds and large institutions have $251M invested in Athira Pharma in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
48% less capital invested
Capital invested by funds: $484M → $251M (-$233M)
49% less call options, than puts
Call options by funds: $2.01M | Put options by funds: $3.94M
Holders
89
Holding in Top 10
–
Calls
$2.01M
Puts
$3.94M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$7.8M | |
| 3 | +$6.02M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.25M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.1M |
Top Sellers
| 1 | -$39M | |
| 2 | -$30.9M | |
| 3 | -$15.9M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.37M |
| 5 |
RI
RTW Investments
New York
|
-$7.64M |